Data / Form D filings / ReNewVax Ltd
ReNewVax Ltd: Form D filing
ReNewVax Ltd, a biotechnology company in Liverpool, United Kingdom, filed a Form D with the SEC in 2023. The latest, on May 31, 2023, reports an offering of $3 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- RONALD ROSS BUILDING, 8 WEST DERBY STREET, Liverpool, United Kingdom, L69 7
- Phone
- 001133761442277
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Year incorporated
- 2022
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1979470
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 31, 2023 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Neil David Murray | Director |
Every Form D from the week of May 29, 2023 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ReNewVax Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.